Newsletter subscription & archive

Freudenberg Medical is looking for new methods and technologies in pharma and biotech


Written byPer Spindler

Freudenberg Medical is looking for new methods and technologies in several areas including anti-microbial and anti-inflammatory approaches (no pharmaceuticals), reduction of reaction against implants, smart coatings, fast bioburden detection, efficacy testing methods, minimally invasive systems, drug delivery, biosensors and in vitro diagnostics

Health Axis Europe Partnering is currently scouting for Freudenberg Medical. Freudenberg Medical is looking for new methods and technologies in several areas

  • Anti-inflammatory approaches (for wound care, for (soft) implants, for blood filtration, no pharmaceuticals)
  • Strategies for reduction of foreign body reaction (for implants, most out of silicone, and attached Freudenberg product presentations from FM and FPM)
  • Smart dressings / smart coatings (smart about wound healing information)
  • Anti-microbial approaches for silver substitution (no pharmaceuticals)
  • Bioburden detection (on surfaces and/or in air, quick and dirty, particularly < 10 CFU/ cm2)
  • Ex vivo/ in vitro methods for efficacy testing (new methods) for the topics above
  • Minimally invasive systems/surgery (electrification, digitalization or/and connectivity)
  • Drug delivery
  • Biosensors
  • In vitro diagnostics
  • "Medical needs for the future"

Deadline for submission of proposals is 30 August 30 2019.

Please contact Friedemann Loos (BioRN) or Per Spindler (Biopeople) for further information and application templates.

Health Axis Europe

Health Axis Europe is four biomedical clusters with a common innovation culture. The biomedical clusters in Leuven, Heidelberg, Maastricht and Copenhagen share a common innovation culture, are comparable in strength and have complementary areas of expertise: internationally outstanding universities, substantial health industry base and focused on complementary health technology areas covering medical electronics and nanotechnology (Leuven), personalized medicine and cancer research (Heidelberg), high-performance biomedical materials and Regenerative Medicine (Maastricht) as well as pharmacology and public health science (Copenhagen). The purpose of the Health Axis Europe initiative is to cross-leverage the innovation resources and thus jointly increase the international competitiveness of the clusters in Leuven, Heidelberg, Maastricht and Copenhagen. ​

  • Facilitate and coordinate EU-funded collaborative R&D projects (H2020, Horizon Europe, EIT Health IMI etc.)

  • Support of cross-border cooperation in the training and further education of talented persons

  • Nurture an international startup culture and attract cross-border investments

  • Mediate international partnering between academia, SMEs and global healthcare companies

  • Facilitate scientific exchange in fast evolving visionary health research topics

What are you looking for?